Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial

IMPORTANCE: Atopic dermatitis (AD) is a chronic, recurrent, inflammatory skin disease with an unmet need for treatments that provide rapid and high levels of skin clearance and itch improvement. OBJECTIVE: To assess the safety and efficacy of upadacitinib vs dupilumab in adults with moderate-to-seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Blauvelt, Andrew, Teixeira, Henrique D., Simpson, Eric L., Costanzo, Antonio, De Bruin-Weller, Marjolein, Barbarot, Sebastien, Prajapati, Vimal H., Lio, Peter, Hu, Xiaofei, Wu, Tianshuang, Liu, John, Ladizinski, Barry, Chu, Alvina D., Eyerich, Kilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340015/
https://www.ncbi.nlm.nih.gov/pubmed/34347860
http://dx.doi.org/10.1001/jamadermatol.2021.3023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340015/
https://www.ncbi.nlm.nih.gov/pubmed/34347860
http://dx.doi.org/10.1001/jamadermatol.2021.3023

Ejemplares similares